Eli Lilly shares rose 3.37% on October 22
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
Recap by typeshit. Post by Facebook on Facebook.
See it on Facebook
More peptides
-
Jack Osbourne shares his thoughts on Ozempic and growing up with body image issues 
Jack Osbourne shares his thoughts on Ozempic and growing up with body image issues
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
-
Scott Carney makes the case for buying peptides on the black market 
29:53
Scott Carney makes the case for buying peptides on the black market
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
-
The Precision Peptide Company secures exclusive rights to make its needle-free line The Precision Peptide Company secures exclusive rights to make its needle-free line
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
-
Dr. Salas-Whalen urges education over fear when weighing GLP-1 medications 
Dr. Salas-Whalen urges education over fear when weighing GLP-1 medications
The endocrinologist says fear, judgment and misinformation still shape how people see GLP-1 drugs, and asks patients to learn before deciding.
-
Facebook post warns compounded tirzepatide users about the end of the shortage 
peptides typeshitLegalFacebook post warns compounded tirzepatide users about the end of the shortage
A Facebook user explains that compounded GLP-1 versions were allowed during the branded drug shortage and flags what that means for people still using them.
-
Jeff Krasno asks dietitian Ashley Koff what to eat while on tirzepatide 
peptides typeshitSafetyJeff Krasno asks dietitian Ashley Koff what to eat while on tirzepatide
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.